Richard D. Kennedy
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 10
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 11
- PARP inhibition in cancer therapy 10
- Molecular Biology top 2%
- DNA Repair Mechanisms 25
- CRISPR and Genetic Engineering 9
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 10
- Epidemiology top 2%
-
- BRCA gene mutations in cancer 17
-
- interferon and immune responses 8
- Co-authors
- Alan D. D’AndreaPaul B. MullanD. Paul HarkinJohn C. KennedyLyle J. MicheliJon J.P. WarnerPatrick G. JohnstonJennifer E. Quinn
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Richard D. Kennedy
110 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.1k
- Oncology 1.8k
- Molecular Biology 3.0k
- Reproductive Medicine 337
- Epidemiology 1.1k
Countries citing papers authored by Richard D. Kennedy
This map shows the geographic impact of Richard D. Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Kennedy more than expected).
Fields of papers citing papers by Richard D. Kennedy
This network shows the impact of papers produced by Richard D. Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Kennedy. The network helps show where Richard D. Kennedy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard D. Kennedy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 50 | |
| 9 | 2020 | 14 | |
| 10 | 2019 | 17 | |
| 11 | 2018 | 45 | |
| 12 | 2016 | 35 | |
| 13 | 2015 | 64 | |
| 14 | 2013 | 44 | |
| 15 | 2011 | 34 | |
| 16 | 2011 | 25 | |
| 17 | 2005 | 71 | |
| 18 | BRCA1 regulates the interferon gamma-mediated apoptotic response. | 2003 | 2 |
| 19 | Genetic testing for BRCA1 mutation in the UK [4] (multiple letters) | 2003 | 1 |
| 20 | Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma | 2001 | 3 |
About Richard D. Kennedy
Richard D. Kennedy is a scholar working on Cancer Research, Oncology and Reproductive Medicine, having authored 117 papers that have together received 6.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (25 papers), BRCA gene mutations in cancer (17 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (10 papers), Ovarian cancer diagnosis and treatment (10 papers), PARP inhibition in cancer therapy (10 papers), CRISPR and Genetic Engineering (9 papers) and interferon and immune responses (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.8k citations) and Molecular Biology (3.0k citations). Richard D. Kennedy has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Alan D. D’Andrea, Paul B. Mullan, D. Paul Harkin, John C. Kennedy, Lyle J. Micheli, Jon J.P. Warner, Patrick G. Johnston, D. Paul Harkin, Jennifer E. Quinn and J. E. Quinn. Their work appears in journals such as New England Journal of Medicine, Cell and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.